Hepatitis E

Acute INFLAMMATION of the LIVER in humans; caused by HEPATITIS E VIRUS, a non-enveloped single-stranded RNA virus. Similar to HEPATITIS A, its incubation period is 15-60 days and is enterically transmitted, usually by fecal-oral transmission.

Drugs by status

Approved for this indication (1)

hepatitis e vaccine

Phase 4 trials (1)

ribavirin

Phase 2 trials (1)

sofosbuvir

Phase 1 trials (1)

hev 239

Organizations

Organization Involved with Phase 4 Indications (9)

Sykehuset Innlandet HF
University of Michigan
Xiamen University
International Center for Diarrheal Disease Research
Government of China
Universidad Autonoma de Barcelona
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Xiamen Center for Disease Control and Prevention
Government of Norway

Organization Involved with Phase 3 Indications (6)

Madaus Inc
Alexandria University
Tanta University
University of Maryland
The Egyptian Company for Blood Transfusion Services
Banha Fever Hospital

Organization Involved with Phase 2 Indications (10)

Gilead Sciences
GlaxoSmithKline
German Liver Foundation
National Institute of Allergy and Infectious Diseases (NIAID)
United States Army
Gottfried Wilhelm Leibniz Universität Hannover
All India Institute of Medical Sciences
German Center for Infection Research
Government of Thailand
Hannover Medical School

Organization Involved with Phase 1 Indications (1)

Changchun Institute of Biological Products Co., Ltd.